Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Medanta commences operations at new 550-bed hospital in Noida
The new Medanta Noida facility opens with 300 operational beds, advanced technology and over 60 senior clinical experts
BSI and CAHO collaborate to help transform hospital care in India
Implementation of first international consensus-based healthcare quality standard (ISO 7101) enables reduced waiting times,…
Fortis Healthcare signs 15-year lease for multi-specialty hospital in Greater Noida
Fortis Healthcare takes full operational and financial control of a ~200-bed facility under new lease agreement with RR…
Researchers call for updated diagnostic criteria for behavioural variant frontotemporal dementia
Study in Alzheimer’s & Dementia highlights limitations of current criteria for diagnosing bvFTD, using 14 years of patient…
AliveCor launches AI-powered Kardia 12L handheld ECG system in India with CDSCO approval
The handheld 12-lead ECG device detects 35 cardiac determinations, including acute myocardial infarction and cardiac ischemia, and…
- Advertisement -
Invicta Diagnostic secures in-principle NSE Emerge approval for IPO to raise ₹28 crore
Mumbai-based diagnostic chain plans fresh issue of 33.08 lakh equity shares to fund expansion of centres in Maharashtra
Novo Nordisk, Apollo Clinics partner to launch obesity clinic program in India
The partnership aims to strengthen disease awareness, capacity building and clinical management for overweight and obesity care
Mahajan Imaging & Labs, Fortis La Femme partner for women and child healthcare & diagnosis…
The alliance aims to create an ecosystem for women’s and children’s health, focused on early detection, precise diagnosis, and…
IIITH hosts ABDM 2.0 southern region consultation meeting organised by NHA
Panels included members from NHA, state government, research institutions, healthcare providers, NGOs, medical colleges &…
Zydus Therapeutics reports positive topline results from EPICS-III Phase 2(b)/3 Trial of…
The trial met its primary composite endpoint, with a treatment difference in achieving a biochemical response of 48.5 per cent,…